Logo-apb
Adv Pharm Bull. 2021;11(3): 414-425. doi: 10.34172/apb.2021.049
PMID: 34513616        PMCID: PMC8421632

Review Article

The Beginning of a New Era: Artificial Intelligence in Healthcare

Akshara Kumar 1 ORCID, Shivaprasad Gadag 1, Usha Yogendra Nayak 1 * ORCID

Cited by CrossRef: 7


1- Shaikh F, Afshan G, Anwar R, Abbas Z, Chana K. Analyzing the impact of artificial intelligence on employee productivity: the mediating effect of knowledge sharing and well‐being. Asia Pac J Human Res. 2023;61(4):794 [Crossref]
2- Hasan H, Jaber D, Al Tabbah S, Lawand N, Habib H, Farahat N, Farrukh M. Knowledge, attitude and practice among pharmacy students and faculty members towards artificial intelligence in pharmacy practice: A multinational cross-sectional study. PLoS ONE. 2024;19(3):e0296884 [Crossref]
3- Deo N, Anjankar A. Artificial Intelligence With Robotics in Healthcare: A Narrative Review of Its Viability in India. 2023; [Crossref]
4- KELEŞ H. TIPTA YAPAY ZEKA UYGULAMALARI. 2022;24(3):604 [Crossref]
5- e Siqueira T, Parraça J, Sousa J. Available rehabilitation technology with the potential to be incorporated into the clinical practice of physiotherapists: A systematic review. Health Science Reports. 2024;7(4) [Crossref]
6- Roy S, Meena T, Lim S. Demystifying Supervised Learning in Healthcare 4.0: A New Reality of Transforming Diagnostic Medicine. Diagnostics. 2022;12(10):2549 [Crossref]
7- Battineni G, Chintalapudi N, Ricci G, Ruocco C, Amenta F. Exploring the integration of artificial intelligence (AI) and augmented reality (AR) in maritime medicine. Artif Intell Rev. 2024;57(4) [Crossref]
8- Younesi A, Ansari M, Fazli M, Ejlali A, Shafique M, Henkel J. A Comprehensive Survey of Convolutions in Deep Learning: Applications, Challenges, and Future Trends. IEEE Access. 2024;12:41180 [Crossref]
9- Al Kuwaiti A, Nazer K, Al-Reedy A, Al-Shehri S, Al-Muhanna A, Subbarayalu A, Al Muhanna D, Al-Muhanna F. A Review of the Role of Artificial Intelligence in Healthcare. JPM. 2023;13(6):951 [Crossref]
10- Lik Au S. Artificial Intelligence Systems for Diabetic Retinopathy Screening: Appraisal on the 3rd US FDA Approved Algorithms- AEYE-DS. JOAR. 2023;:1 [Crossref]